No draft has been generated for Mark Graves under any (sender, voice, purpose, target-role) combination yet.
Age: 52 · Location: UK · Frame: operator (Y1 lockup — approach 2027) · Judge tier: BN · Judge Focus-44 rank: 18
CEO Ergéa UK (effective 24-Nov-2025); director 11 Ergéa UK entities
4-OEM cross-modality career (Getinge, Johnson & Johnson, Olympus, GE Healthcare) landing as fresh CEO Ergéa UK 24-Nov-2025.
4-OEM cross-modality career (Getinge / J&J / Olympus / GE Healthcare); fresh CEO seat Ergéa UK effective 24-Nov-2025.
Ergéa UK CEO from 2025-11-24; 25yr life-sci across Getinge / JJ / Olympus KeyMed / GE Healthcare / Applied Biosystems 4-OEM cross-modality (Lin 44-walk).
Vmm P1 (msg-jk3606): DOB 1974; Director across all Medipass/Asteral entities from 2026-02-19; person_id-consistent with Ergéa UK CEO effective 24-Nov-2025. Serendipity via Muolo Medipass overlap query.
LOCKED (first-year CEO tenure)
Outreach window: 2027+
Ergéa UK team bench (Rolfe / Muolo / Wheeler)
operator (Y1 lockup — approach 2027) · Halma/Roper/Diploma consolidator · L4 bracket UNMAPPED · L1=0 L2=3 L4=3 L5=0 L6=1
Path to seat: oem_leaver_to_pl_fresh
Data gap: First-year defer; approach 2027 after settling
Data gap: L6 evidence-only rescore: Fresh CEO seat 24-Nov-2025 = first-year lockup; too new for a forward-motion read